Related Experiment Video
Updated: Aug 11, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
Cryptococcosis in apparently immunocompetent patients
1Division of Infectious Diseases, Department of Medicine and Therapeutics, 9/F Clinical Sciences Building, Prince of Wales Hospital, Hong Kong.
Insights
Cryptococcosis affects immunocompetent individuals, often presenting as indolent meningitis with better outcomes. This fungal infection requires careful diagnosis and management in all patient groups.
Area of Science:
- Infectious Diseases
- Mycology
- Clinical Microbiology
Background:
- Cryptococcosis is a fungal infection with limited reported data on immunocompetent patients.
- Understanding cryptococcosis in immunocompetent individuals is crucial due to its potential impact.
Purpose of the Study:
- To compare the clinical presentations and outcomes of cryptococcosis between immunocompetent and immunocompromised patients.
- To identify differences in disease manifestation and prognosis based on immune status.
Main Methods:
- A retrospective case series of 46 confirmed cryptococcosis cases in Hong Kong hospitals (1995-2005).
- Data collected included clinical presentations, fungemia rates, cerebrospinal fluid (CSF) parameters, and outcomes.
- Cases were categorized into immunocompetent, immunocompromised (non-HIV), and HIV-positive groups.
Main Results:
- Nearly half (43.5%) of patients were immunocompetent, with *Cryptococcus gattii* being a common cause in this group.
- Immunocompetent patients more frequently presented with meningitis (80.0%) and showed a trend towards lower fungemia (10.0%) and mortality rates (25.0%).
- In cryptococcal meningitis, immunocompetent patients experienced longer onset-to-presentation times, more intense inflammatory responses, less fungemia, and better clinical outcomes (81.3%) compared to immunocompromised patients (46.7%).
Conclusions:
- A significant portion of cryptococcosis cases occur in apparently immunocompetent individuals.
- Both *Cryptococcus neoformans* var. *grubii* and *Cryptococcus gattii* are identified as common causative agents.
- Immunocompetent patients typically exhibit localized, indolent neurological disease with robust inflammatory responses but favorable prognoses.
Background:
Few reports have described the clinical and microbiological features of cryptococcosis in immunocompetent patients.
Aim:
To compare clinical presentations and outcomes of cryptococcosis in immunocompetent vs. immunocompromised patients.
Design:
Retrospective case series.
Methods:
All culture- or histology-confirmed cases (n = 46) of cryptococcosis in two acute hospitals in Hong Kong (1995-2005) were included. Clinical presentations, rates of fungaemia, cerebrospinal fluid (CSF) parameters and clinical outcomes were recorded.
Results:
Twenty patients (43.5%) were apparently immunocompetent, 17 (37.0%) had predisposing factors other than HIV infection, and 9 (19.6%) were HIV-positive. Thirty-one (67.4%) presented with meningitis, four (8.7%) with pulmonary cryptococcosis, and 11 (23.9%) with extraneural, extrapulmonary cryptococcosis. Of the immunocompetent patients with retrievable isolates (n = 8), three (37.5%) were Cryptococcus gattii; all isolates (n = 6) from immunocompromised patients were Cryptococcus neoformans var. grubii. Immunocompetent patients more commonly presented with meningitis (80.0% vs. 47.1%, p = 0.03), and tended toward lower rates of fungaemia (10.0% vs. 35.3%, p = 0.06) and mortality (25.0% vs. 52.9%, p = 0.06). Death was associated with fungaemia (p = 0.01) and underlying malignancy (p < 0.01). In cryptococcal meningitis, immunocompetent patients had longer mean time from illness onset to presentation (34.4 vs. 12.6 days, p = 0.02), more intense inflammatory responses (CSF: white blood cells 108 vs. 35 x 10(9)/l, p = 0.03; protein 1.61 g/l vs. 0.79 g/l, p = 0.07), less fungaemia (0% vs. 26.7%, p = 0.04) and more satisfactory clinical outcomes (81.3% vs. 46.7%, p = 0.04).
Discussion:
A substantial proportion of patients with cryptococcosis are apparently immunocompetent. C. neoformans var. grubii and C. gattii are the common causes. Immunocompetent patients tend to present with localized, indolent neurological disease, with more intense inflammatory responses but better clinical outcomes.
Related Concept Videos
Cryptococcal Meningitis
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Toxoplasmosis
Fungal Phylum Microsporidia